Microchip success for bionic eye

April 3, 2012
Microchip for the bionic eye

(Medical Xpress) -- Research to restore sight to the clinically blind has reached a critical stage, with testing underway of the prototype microchips that will power the bionic eye.

Electrical engineers from the Monash Vision Group (MVG) have begun trailling the , with early laboratory tests proving positive, and pre-clinical assessment due to begin shortly.

The Director of MVG, Professor Arthur Lowery said the positive result meant the project was on track to deliver a direct-to-brain bionic ready for patient tests in 2014.

The device will consist of a mounted into a pair of glasses, which acts as the retina; a pocket processor, which takes the electronic information from the camera and converts it into signals enabling the brain to build up a visual construct; and cortical implants of several tiles which will be the portal for the stimulation of the .

“The aim for this vision prosthetic is to be at least equivalent to a seeing-eye dog or a white cane. While it would initially complement existing aids such as these, we believe the device eventually will replace them, and as the technology is further refined, become sufficiently sensitive to discriminate large print,” Professor Lowery said.

“The microchips we are testing will be implanted directly on the surface of a patient’s visual cortex, located at the back of the brain. It’s estimated that each patient will receive a grid of up to 14 eight-by-eight millimetre tiles,” Professor Lowery said.

Each tile comprises a four-by-four millimeter microchip with some 500,000 transistors and 45 hair-thin electrodes. When fully operational, these tiles will receive low-resolution, black-and-white images from an external digital processing unit connected to a high-resolution camera.

Dr. Jean-Michel Redouté, MVG’s Program Leader, Implantable Electronics, said one of the project’s main challenges was harnessing and powering this array of electrically-charged devices in the brain.

“Achieving acceptable vision requires far more electrode capacity than the amount required to power a bionic ear. While the bionic ear requires approximately 15 electrodes, we’ll need at least 600 to produce useful vision for patients,” Dr. Redouté said.

Over 50,000 people in Australia are considered clinically blind. The number exceeds 160 million globally .

The MVG was established in April 2010, with an $8 million grant from the Australian Research Council. The MVG accommodates more than 20 leaders in physiology, neurosurgery, ophthalmology, electrical and electronic engineering, mechanical and materials engineering, mathematics and immunology.

Explore further: Electrical stimulation to help the blind see

Related Stories

Electrical stimulation to help the blind see

October 12, 2011
(Medical Xpress) -- In people who have lost vision due to an injury or disease, the brain is still capable of "seeing." Researchers from the Massachusetts Institute of Technology’s Cognitive and Brain Science Department ...

‘Eyeborg’ man films vision of future (w/ video)

August 30, 2011
(PhysOrg.com) -- A Canadian filmmaker whose childhood hero was Lee Majors as a bionic man is making the most out of what he has done to compensate for having lost one eye by becoming Eyeborg Man. Rob Spence, who lost an eye ...

Recommended for you

Research reveals biological mechanism of a leading cause of childhood blindness

November 16, 2017
Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.

Genetic treatment for blindness may soon be reality

November 11, 2017
Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting ...

Study finds donor corneas can be safely preserved for longer period

November 10, 2017
Results from a large, national clinical trial show that corneal donor tissue can be safely stored for 11 days without negatively impacting the success of transplantation surgery to restore vision in people with diseases of ...

Exploring the genetics of glaucoma and retinal development

November 10, 2017
Guillermo Oliver, PhD, the Thomas D. Spies Professor of Lymphatic Metabolism, recently published two studies related to the eye, one on retinal formation and the other on the genetics behind glaucoma.

Scientists discover potential treatment to stop glaucoma in its tracks

November 6, 2017
Vision scientists at the University of California, Berkeley, and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, ...

New focus on correcting refractive vision

October 25, 2017
While doctors take delight in solving the common issue of refractive vision error by prescribing eye glasses, Flinders University researchers have found that many patients are upset with this solution and claim it affects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.